Investors

|

Portal
Order
Home / Research / Publications / Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes

Publications

Back

Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes

– Caris Life Sciences

Poster

Conclusions

  • RCC1 expression is a negative prognostic marker in NSCLC, PC, and CRC
  • Further studies to investigate this at the molecular level may be a potential opportunity for novel targeted drug development
Download Publication

Discover
More

  • The mechanism of mismatch repair deficiency (MMRd) informs survival outcomes derived from immune checkpoint blockade (ICB) across MMRd solid tumors

    – Caris Life Sciences

    Manuscript

    Background MMRd/Microsatellite instability (MSI) High tumors represent the first tumor-agnostic indication for ICB. Emerging data suggest that the specific MMR protein lost and the mechanism… […]

  • Characterization of Plasma Cell-Free DNA Variants as ofTumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients

    – Caris Life Sciences

    Manuscript

    Abstract Purpose: Plasma-based liquid biopsy tests can detect tumorspecific genetic alterations and offer many advantages that complement tissue-based comprehensive genomic profiling. However, age-related clonal hematopoiesis… […]
Learn More

Ready to Get Started on the Journey?